Literature DB >> 23581868

Anxiety disorders and drug dependence: evidence on sequence and specificity among adults.

Renee D Goodwin1, Dan J Stein.   

Abstract

AIM: The goal of this study was to investigate the relation between specific anxiety disorders and substance dependence, adjusting for potentially confounding demographic factors (e.g. sex) and comorbidity (e.g. alcohol dependence, major depression), among adults in the USA.
METHODS: Data were drawn from the National Comorbidity Survey (NCS), a nationally representative population sample of the US adult population aged 15-54. The temporal sequence of onset of anxiety and substance dependence disorders was examined.
RESULTS: Substance dependence temporally precedes several anxiety disorders, particularly panic disorder. Specifically, a history of past substance dependence predicts current panic disorder (odds ratio [OR] =2.62, 95% confidence interval [CI] =1.29, 5.32), social phobia (OR=1.7, 95%CI=1.12, 2.41), and agoraphobia (OR=1.78, 95%CI=1.08, 2.94). Conversely, in more than 50% of substance abuse disorder cases, in nearly 40% of post-traumatic stress disorder (PTSD) cases, and in nearly 30% of generalized anxiety disorder (GAD) cases, the anxiety disorder has first onset. Similarly, a lifetime history of social phobia, PTSD, or GAD significantly predicts lifetime substance dependence (OR=1.51 for social phobia, 2.06 for PTSD, 1.45 for GAD).
CONCLUSION: For any particular anxiety disorder, a diagnosis of substance abuse can occur prior to or subsequent to an anxiety disorder. Nevertheless, there is also evidence for the specificity of some associations between anxiety and substance dependence disorders; these are independent of the effects of sex and other comorbid disorders, may be causal in nature, and deserve particular attention in clinical settings. The possibility that within a particular anxiety disorder there are a variety of mechanisms of association with various substances should be addressed in future work.
© 2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology.

Entities:  

Mesh:

Year:  2013        PMID: 23581868      PMCID: PMC3701305          DOI: 10.1111/pcn.12030

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  40 in total

1.  Do deviant peer associations mediate the contributions of self-esteem to problem behavior during early adolescence? A 2-year longitudinal study.

Authors:  David L DuBois; Naida Silverthorn
Journal:  J Clin Child Adolesc Psychol       Date:  2004-06

Review 2.  Extent of illicit drug use and dependence, and their contribution to the global burden of disease.

Authors:  Louisa Degenhardt; Wayne Hall
Journal:  Lancet       Date:  2012-01-07       Impact factor: 79.321

Review 3.  Advances in strategies for minimizing and adjusting for survey nonresponse.

Authors:  R C Kessler; R J Little; R M Groves
Journal:  Epidemiol Rev       Date:  1995       Impact factor: 6.222

4.  Considering comorbidity in social phobia.

Authors:  Mariette J Chartier; John R Walker; Murray B Stein
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2003-12       Impact factor: 4.328

5.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

6.  Panic attacks, depression and anxiety symptoms, and substance use behaviors during late adolescence.

Authors:  David P Valentiner; Nina S Mounts; Brett J Deacon
Journal:  J Anxiety Disord       Date:  2004

Review 7.  Dopamine in drug abuse and addiction: results from imaging studies and treatment implications.

Authors:  N D Volkow; J S Fowler; G-J Wang; J M Swanson
Journal:  Mol Psychiatry       Date:  2004-06       Impact factor: 15.992

8.  The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey.

Authors:  D G Blazer; R C Kessler; K A McGonagle; M S Swartz
Journal:  Am J Psychiatry       Date:  1994-07       Impact factor: 18.112

9.  Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder.

Authors:  H U Wittchen; R C Kessler; S Zhao; J Abelson
Journal:  J Psychiatr Res       Date:  1995 Mar-Apr       Impact factor: 4.791

Review 10.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review.

Authors:  H U Wittchen
Journal:  J Psychiatr Res       Date:  1994 Jan-Feb       Impact factor: 4.791

View more
  5 in total

1.  Substance Use and Associated Health Conditions throughout the Lifespan.

Authors:  Marya T Schulte; Yih-Ing Hser
Journal:  Public Health Rev       Date:  2014

Review 2.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

3.  Which factors influence psychiatric diagnosing in substance abuse treatment?

Authors:  Rolf Wynn; Anne Landheim; Ellen Hoxmark
Journal:  Int J Ment Health Syst       Date:  2013-06-06

Review 4.  A High-Sugar Diet Consumption, Metabolism and Health Impacts with a Focus on the Development of Substance Use Disorder: A Narrative Review.

Authors:  Kacper Witek; Karolina Wydra; Małgorzata Filip
Journal:  Nutrients       Date:  2022-07-18       Impact factor: 6.706

Review 5.  Management of chronic pain with chronic opioid therapy in patients with substance use disorders.

Authors:  Yu-Ping Chang; Peggy Compton
Journal:  Addict Sci Clin Pract       Date:  2013-12-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.